Atlas Trials

Senolytic Therapy to Modulate Progression of Alzheimer's Disease

Clinical trial NCT04063124 · COMPLETED

Trial details

NCT number
NCT04063124
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2020-02-14
Primary completion
2021-12-10
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.